Survival of patients with disseminated midgut carcinoid tumors after aggressive tumor reduction

World Journal of Surgery

Volumn 20, Issue 7, 1996, Pages 892-899

  Wangberg B ^a   Westberg, G ^a   Tylen U ^a   Tisell, L E ^a   Jansson, S ^a   Nilsson, O ^a   Johansson, V ^a   Schersten T ^a   Ahlman, H ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; OCTREOTIDE; SOMATOSTATIN RECEPTOR;

ADULT; AGED; ARTIFICIAL EMBOLISM; AUTOPSY; CANCER SURVIVAL; CARCINOID SYNDROME; CLINICAL ARTICLE; CONFERENCE PAPER; DIAGNOSTIC ACCURACY; FEMALE; FOLLOW UP; HUMAN; LIVER METASTASIS; MALE; RISK FACTOR; SCINTIGRAPHY; SURVIVAL RATE; TREATMENT PLANNING; TUMOR DIAGNOSIS; TUMOR GROWTH;

ADULT; AGED; ANTINEOPLASTIC AGENTS, HORMONAL; CARCINOID TUMOR; CAUSE OF DEATH; CLINICAL PROTOCOLS; COMBINED MODALITY THERAPY; DEATH, SUDDEN, CARDIAC; EMBOLIZATION, THERAPEUTIC; FEMALE; FOLLOW-UP STUDIES; HEPATIC ARTERY; HUMANS; HYDROXYINDOLEACETIC ACID; INDIUM RADIOISOTOPES; INTESTINAL NEOPLASMS; LIVER NEOPLASMS; MALE; MIDDLE AGED; OCTREOTIDE; PENTETIC ACID; RADIOPHARMACEUTICALS; RECEPTORS, SOMATOSTATIN; REMISSION INDUCTION; RISK FACTORS; SURVIVAL ANALYSIS; SURVIVAL RATE;

EID: 20244387404     PISSN: 03642313     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002689900136     Document Type: Conference Paper

References (46)

1. Williams, E., Sandler, M.: The classification of carcinoid tumours. Lancet 1:238, 1963
2. Grahame-Smith, D.G.: The Carcinoid Syndrome, London, Heinemann, 1972
3. Berge, T., Linell, F.: Carcinoid tumors. Acta Pathol. Microbiol. Scand. [A] 84:322, 1976
4. Godwin, J.: Carcinoid tumors: an analysis of 2837 cases. Cancer 36:560, 1975
5. Greenberg, R., Baumgarten, D., Clark, W., Isacson, P., McKeen, K.: Prognostic factors for gastrointestinal and bronchopulmonary carcinoid tumors. Cancer 60:2476, 1987
6. McDermott, E., Guduric, B., Brennan, M.: Prognostic variables in patients with gastrointestinal carcinoid tumours. Br. J. Surg. 81:107, 1994
7. Moertel, C., Sauer, W., Dockerty, M., Baggenstoss, A.: Life history of the carcinoid tumour of the small intestine. Cancer 14:901, 1961
8. Davis, Z., Moertel, C., McIlrath, D.: The malignant carcinoid syndrome. Surg. Gynecol. Obstet. 137:637, 1973
9. Zeitels, J., Naunheim, K., Kaplan, E.L., Straus, F.: Carcinoid tumors: a 37-year experience. Arch. Surg. 117:732, 1982
10. Soga, J., Tazawa, K.: Pathologic analysis of carcinoids: Histologic reevaluation of 62 cases. Cancer 25:990, 1971
11. Johnson, L., Lavin, P., Moertel, C., et al.: Carcinoids: the association of histologic growth pattern and survival. Cancer 51:882, 1983
12. Capella, C., Heitz, P., Höfler, H., Solcia, E., Klöppel, G.: Revised classification of neuroendocrine tumors of the lung, pancreas and gut. Digestion 55:11, 1994
13. Ahlman, H., Wängberg, B., Tisell, L.E., Nilsson, O., Fjälling, M., Forssell-Aronsson, E.: Clinical efficacy of octreotide scintigraphy in patients with midgut carcinoid tumours and evaluation of intraoperative scintillation detection. Br. J. Surg. 81:1144, 1994
14. Ahlman, H., Wängberg, B., Jansson, S., et al.: Management of disseminated midgut carcinoid tumours. Digestion 49:78, 1991
15. Dowling, R., Hussaini, S., Murphy, G., Besser, G., Wass, J.: Gallstones during octreotide therapy. Metabolism 41(Suppl. 2):22, 1992
16. Maton, P., Camilleri, M., Graffin, G., Allison, D., Hodgson, H., Chadwick, V.: Role of hepatic artery embolisation in the carcinoid syndrome. B.M.J. 257:932, 1983
17. Bengmark, S., Rosengren, K.: Angiographic study of the collateral circulation to the liver after ligation of the hepatic artery in man. Am. J. Surg. 119:620, 1970
18. Geterud, K., Tylén, U., Jansson, S., Stenqvist, O., Tisell, L-E., Ahlman, H.: Hepatic arterial embolisation in the treatment of the midgut carcinoid syndrome and other advanced endocrine tumours metastatic to the liver. J. Intervent. Radiol. 5:69, 1990
19. Ahlman, H., Åhlund, L., Dahlström, A., Martner, J., Stenqvist, O., Tylén, U.: SMS 201-995 and provocation tests in preparation of patients with carcinoids for surgery or hepatic arterial embolization. Anesth. Analg. 67:1142, 1988
20. Murray-Lyon, I., Rake, M., Marshall, A., Williams, R.: Malignant carcinoid tumour with gangrene of the small intestine. B.M.J. 4:770, 1973
21. Sworn, M., Reasbeck, P., Buchanan, R.: Intestinal ischemia associated with ileal carcinoid tumours. Br. J. Surg. 65:313, 1978
22. Eckhauser, F., Argenta, L., Strodel, W.: Mesenteric angiopathy, intestinal gangrene, and midgut carcinoids. Surgery 90:720, 1981
23. Harvey, J., Denyer, M., DaCosta, P.: Intestinal infarction caused by carcinoid-associated elastic vascular sclerosis: early presentation. Gut 50:371, 1989
24. Strodel, W., Talpos, G., Eckhauser, F., Thompson, N.: Surgical therapy for small-bowel carcinoid tumors. Arch. Surg. 118:391, 1983
25. Martin, J., Moertel, C., Adson, M., Schutt, A.: Surgical treatment of functioning metastatic carcinoid tumors. Arch. Surg. 118:537, 1983
26. McEntee, G., Nagorney, D., Kvols, L., Moertel, C., Grant, C.: Cytoreductive hepatic surgery for neuroendocrine tumors. Surgery 108:1091, 1990
27. Norton, J.: Surgical management of carcinoid tumors: role of debulking and surgery for patients with advanced disease. Digestion 55:98, 1994
28. Gelin, L.E., Lewis, D., Nilsson, L.: Liver blood flow in man during abdominal surgery: the effect of hepatic artery occlusion on the blood flow through metastatic tumour nodules. Acta Hepatosplen. (Stuttg.) 15:21, 1968
29. Cho, K., Reuter, S., Schmidt, R.: Effects of experimental hepatic artery embolization on hepatic function. Am. J. Radiol. 27:563, 1976
30. Chuang, V., Wallace, S.: Hepatic artery embolization in the treatment of hepatic neoplasms. Radiology 140:51, 1981
31. Allison, D., Modlin, I., Jenkins, W.: Treatment of carcinoid liver metastases by hepatic artery embolization. Lancet 2:1323, 1977
32. Carrasco, C., Charnsangavej, C., Ajani, J., Samaan, N., Richli, W., Wallace, S.: The carcinoid syndrome: palliation by hepatic artery embolisation. Am. J. Radiol. 147:149, 1986
33. Lunderquist, A., Ericsson, M., Nobin, A., Sandén, G.: Gelfoam powder embolization of the hepatic artery in liver metastases of carcinoid tumours. Radiologie 22:65, 1982
34. Mitty, H., Warner, R., Newman, L., Trains, J., Parnes, I.: Control of carcinoid syndrome with hepatic artery embolisation. Radiology 155: 623, 1985
35. Pueyo, I., Jimenez, J., Hernández, J., et al.: Carcinoid syndrome treated by hepatic embolization. A.J.R. 131:511, 1978
36. Wängberg, B., Ahlman, H., Tylén, U., Nilsson, O., Hermodsson, S., Hellstrand, K.: Accumulation of natural killer cells after hepatic artery embolisation in the midgut carcinoid syndrome. Br. J. Cancer 71:617, 1995
37. 1A-receptors regulate a cell-contact-mediated interaction between natural killer cells and monocytes. Scand. J. Immunol. 37:7, 1993
38. Wängberg, B., Geterud, K., Nilsson, O., et al.: Embolisation therapy in the midgut carcinoid syndrome: just tumour ischaemia? Acta Oncol. 52:251, 1993
39. Moertel, C., Rubin, J., Kvols, L.: Therapy of metastatic carcinoid tumour and the malignant carcinoid syndrome with recombinant leucocyte A interferon. J. Clin. Oncol. 7:865, 1989
40. Kvols, L.: Metastatic carcinoid tumors and the carcinoid syndrome: a selective review of chemotherapy and hormonal therapy. Am. J. Med. 81:49, 1986
41. Moertel, C., Johnson, C., McKusick, M., et al.: The management of patients with advanced carcinoid tumors and islet cell carcinomas. Ann. Intern. Med. 120:302, 1994
42. Öberg, K., Funa, K., Alm, G.: Effects of leucocyte interferon on clinical symptoms and hormone levels in patients with midgut carcinoid tumours and the carcinoid syndrome. N. Engl. J. Med. 309:129, 1983
43. Välimäki, M., Järvinen, H., Salmela, P., Sane, T., Sjöblom, S-M., Pelkonen, R.: Is the treatment of metastatic carcinoid tumor with interferon not as successful as suggested? Cancer 67:547, 1991
44. Bartsch, H., Stöckmann, F., Arnold, R., Creutzfeldt, W.: Treatment of patients with metastatic midgut carcinoid tumours by recombinant human interferon-alpha: results from a phase II study. J. Cancer Res. Clin. Oncol. 116:305, 1990
45. Hanssen, L.E., Schrumpf, E., Kolbenstvedt, A.N., Tausjö, J., Dolva, L.Ö.: Treatment of malignant metastatic midgut carcinoid tumours with recombinant human α2b interferon with or without prior hepatic artery embolization. Scand. J. Gastroenterol. 24:787, 1989
46. Jacobsen, M.B., Hanssen, L.E., Kolmannskog, F., Schrumpf, E., Vatn, M.H., Bergan, A.: Interferon-α2b, with or without prior hepatic artery embolisation: clinical response and survival in mid-gut carcinoid patients. Scand. J. Gastroenterol. 30:789, 1995